DAY 4 | 90-second video highlights from the world’s largest cardiology conference
ESC 2017 Wrap-up
| CANTOS – The Canakinumab Anti-Inflammatory Thrombosis Outcomes Study WATCH » |
| Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Primary Results WATCH » |
| Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial WATCH » |
| DETermination of the role of OXygen in suspected Acute Myocardial Infarction WATCH » |
| The Viborg Vascular randomised screening trial WATCH » |
Professor David Brieger
| Meet the Guidelines task force - Focused update on dual antiplatelet therapy developed in collaboration with EACTS WATCH » |
|
Associate Professor John Atherton
| Assessment of REmote HEArt Rhythm Sampling using the AliveCor heart monitor to scrEen for Atrial Fibrillation (The REHEARSE-AF study) WATCH » |
| Lacking treatment effect of ICD in heart failure patients lacking ischemic heart disease and age? A meta-analysis and meta-regression focusing on moderators and the DANISH trial WATCH » |
Dr Vivienne Miller
| Am I missing secondary hypertension? WATCH » |
| Current advancements in renal generation and the SPYRAL HTN |
|
Professor Phillip Newton
| Effectiveness of community atrial fibrillation screening in over 10,000 citizens using smartphone electrocardiogram – The AFinder program WATCH » |
| How can we explain the J curve in hypertensive patients with coronary artery disease? An analysis of 22,672 patients from the CLARIFY registry WATCH » |
| Implementation of modern treatments explains improvements after ST-Elevation Myocardial Infarction (STEMI) over a 20-year period in Sweden from 1995 to 2014 WATCH » |
The Cardiology Today delegates are independently selecting and curating their own sessions for this Australian coverage of ESC Congress 2017 direct from Barcelona.